Fidelity Investments’s Vanguard ESG US Corporate Bond ETF VCEB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88.8K Buy
1,415
+4
+0.3% +$251 ﹤0.01% 4028
2026
Q1
$88.6K Sell
1,411
-4
-0.3% -$254 ﹤0.01% 3847
2025
Q4
$90K Sell
1,415
-13
-0.9% -$833 ﹤0.01% 3813
2025
Q3
$91.7K Buy
1,428
+103
+8% +$6.54K ﹤0.01% 3705
2025
Q2
$84K Sell
1,325
-257
-16% -$16K ﹤0.01% 3683
2025
Q1
$99.5K Buy
1,582
+110
+7% +$6.87K ﹤0.01% 3557
2024
Q4
$91.3K Sell
1,472
-170
-10% -$10.7K ﹤0.01% 3596
2024
Q3
$107K Buy
1,642
+1,194
+267% +$76.1K ﹤0.01% 3443
2024
Q2
$27.8K Buy
448
+130
+41% +$8.03K ﹤0.01% 3914
2024
Q1
$20K Buy
+318
New +$19.9K ﹤0.01% 4020
2023
Q1
Sell
-2
Closed -$121 5540
2022
Q4
$121 Buy
+2
New +$121 ﹤0.01% 4866

Other funds holding VCEB

Fidelity Investments's VCEB Position: Q2 2026 in Review

Fidelity Investments increased its Vanguard ESG US Corporate Bond ETF (VCEB) stake by 0.28% in Q2 2026, buying an estimated $251 and bringing the position to 1,415 shares worth $88.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4028.

Fidelity Investments first reported a position in VCEB in Q4 2022 and has held it in 11 quarters since. The position peaked at $107K in Q3 2024. 141 funds tracked by Wall St. Rank hold VCEB as of Q2 2026.

  • Fidelity Investments held 1,415 shares of Vanguard ESG US Corporate Bond ETF worth $88.8K as of Q2 2026.
  • Fidelity Investments bought 4 Vanguard ESG US Corporate Bond ETF shares in Q2 2026, an estimated $251.
  • Vanguard ESG US Corporate Bond ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4028 holding.
  • Fidelity Investments first reported a position in Vanguard ESG US Corporate Bond ETF in Q4 2022 and has held it in 11 quarters since.
  • Fidelity Investments's Vanguard ESG US Corporate Bond ETF position peaked at $107K in Q3 2024.
  • 141 funds tracked by Wall St. Rank held Vanguard ESG US Corporate Bond ETF as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.